Pacific Bio (NASDAQ: PACB) reported Q1 EPS of ($0.23), $0.02 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $19.1 million versus the consensus estimate of $18.02 million.

For earnings history and earnings-related data on Pacific Bio (PACB) click here.